Immunome Ownership | Who Owns Immunome?
Immunome Ownership Summary
Immunome is owned by 91.29% institutional investors, 11.47% insiders. Blackrock is the largest institutional shareholder, holding 36.46% of IMNM shares. T. Rowe Price Small-Cap Stock is the top mutual fund, with 3.49% of its assets in Immunome shares.
IMNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunome | 91.29% | 11.47% | -2.76% |
| Sector | Healthcare Stocks | 218.58% | 11.00% | -129.58% |
| Industry | Biotech Stocks | 296.15% | 10.91% | -207.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.76M | 36.46% | $45.48M |
| State street | 2.36M | 22.93% | $28.61M |
| T. rowe price investment management | 8.28M | 9.51% | $76.96M |
| Blackrock funding, inc. /de | 5.77M | 6.63% | $53.67M |
| Fmr | 3.92M | 6.51% | $41.62M |
| Ecor1 capital | 3.88M | 6.44% | $41.20M |
| Janus henderson group | 3.46M | 5.74% | $36.73M |
| Redmile group | 4.87M | 5.60% | $45.31M |
| Point72 asset management | 4.69M | 5.39% | $43.58M |
| Vanguard group | 3.00M | 4.99% | $31.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 4.87M | 4.82% | $45.31M |
| Opaleye management | 2.04M | 3.79% | $21.66M |
| Ecor1 capital | 3.88M | 1.56% | $41.20M |
| Nan fung trinity (hk) | 548.85K | 0.61% | $5.10M |
| Birchview capital, lp | 60.00K | 0.55% | $558.00K |
| Sofinnova investments | 778.48K | 0.44% | $7.24M |
| Readystate asset management lp | 1.35M | 0.39% | $12.59M |
| Private capital advisors | 189.84K | 0.22% | $1.77M |
| Jefferies financial group | 2.09M | 0.16% | $19.40M |
| Granahan investment management | 392.75K | 0.15% | $3.65M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.76M | 0.00% | 2.93M |
| State street | 2.36M | 0.00% | 2.16M |
| Readystate asset management lp | 1.35M | 0.39% | 1.13M |
| Polar capital | 1.00M | 0.05% | 1.00M |
| Opaleye management | 2.04M | 3.79% | 802.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | - | - | -1.00M |
| Avidity partners management lp | - | - | -873.89K |
| Brown advisory | - | - | -860.78K |
| Adage capital partners gp | - | - | -775.00K |
| Caption management | - | - | -750.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Polar capital | 1.00M | 0.05% | 1.00M | $9.30M |
| Nan fung trinity (hk) | 548.85K | 0.61% | 548.85K | $5.10M |
| Candriam s.c.a. | 318.09K | 0.02% | 318.09K | $2.96M |
| Natixis | 229.31K | 0.01% | 229.31K | $2.13M |
| Millennium management | 158.43K | 0.00% | 158.43K | $1.68M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Signaturefd | -13.00 |
| Lindbrook capital | -38.00 |
| Russell investments group | -46.00 |
| Stephens consulting | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 148 | 0.68% | 79,432,018 | 9.01% | 91 | 1.08% | 85 | -20.56% | 37 | 105.56% |
| Mar 31, 2025 | 147 | 18.55% | 76,924,342 | 44.29% | 96 | 1.24% | 108 | 54.29% | 17 | -51.43% |
| Dec 31, 2024 | 123 | 1.65% | 53,309,287 | 3.16% | 88 | 1.20% | 69 | 4.55% | 35 | 25.00% |
| Sep 30, 2024 | 121 | 5.22% | 51,674,695 | 8.14% | 85 | 1.35% | 66 | -13.16% | 28 | 27.27% |
| Jun 30, 2024 | 115 | 7.48% | 47,785,575 | 30.06% | 79 | 2.12% | 76 | -12.64% | 22 | 83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock | 3.03M | 3.49% | -3.56K |
| T. Rowe Price US Small-Cap Core Equity | 3.03M | 3.49% | 182.97K |
| Fidelity Growth Compy Commingled Pl S | 2.84M | 3.26% | 601.30K |
| PRIMECAP Odyssey Aggressive Growth | 2.68M | 3.08% | -400.90K |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 2.97% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.19M | 2.52% | -48.70K |
| T. Rowe Price Health Sciences | 2.19M | 2.51% | -82.34K |
| Fidelity Growth Company Fund | 1.98M | 2.27% | 492.00K |
| iShares Russell 2000 ETF | 1.74M | 2.00% | -33.08K |
| Vanguard US Total Market Shares ETF | 1.64M | 1.88% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 03, 2025 | BIENAIME JEAN JACQUES | - | Buy | $46.90K |
| Mar 25, 2025 | BIENAIME JEAN JACQUES | - | Buy | $60.68K |
| Mar 26, 2025 | SIEGALL CLAY B | President and CEO | Buy | $999.46K |
| Mar 24, 2025 | BIENAIME JEAN JACQUES | - | Buy | $57.47K |
| Mar 24, 2025 | Tsai Philip | Chief Technology Officer | Buy | $103.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | 4 | - |
| 2024 Q3 | 1 | 2 |
IMNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools